• 1
    WHO. (2011) Global tuberculosis control: WHO report 2011. Geneva, Switzerland: World Health Organization.
  • 2
    American Thoracic Society. (2000) Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 161: 137695.
  • 3
    Grzybowski S., Fishaut H., Rowe J., Brown A. (1971) Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service. Am Rev Respir Dis 104: 6058.
  • 4
    Horsburgh, C.R., Jr., Rubin E.J. (2011) Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med 364: 14418.
  • 5
    Kunnath-Velayudhan S., Gennaro M.L. (2011) Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery. Clin Microbiol Rev 24: 792805.
  • 6
    Bothamley G.H., Rudd R., Festenstein F., Ivanyi J. (1992) Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonary tuberculosis. Thorax 47: 27075.
  • 7
    Maekura R., Okuda Y., Nakagawa M., Hiraga T., Yokota S., Ito M., Yano I., Kohno H., Wada M., Abe C., Toyoda T., Kishimoto T., Ogura T. (2001) Clinical evaluation of anti-tuberculous glycolipid immunoglobulin G antibody assay for rapid serodiagnosis of pulmonary tuberculosis. J Clin Microbiol 39: 36038.
  • 8
    Silva V.M., Kanaujia G., Gennaro M.L., Menzies D. (2003) Factors associated with humoral response to ESAT-6, 38 kDa and 14 kDa in patients with a spectrum of tuberculosis. Int J Tuberc Lung Dis 7: 47884.
  • 9
    Cavalcante S., Kritski A.L., Ferreira M.A., Souza M.A., Laszlo A., Werneck-Barroso E.B., Fonseca L.S. (1997) Association between an early humoral response to Mycobacterium tuberculosis antigens and later development of tuberculosis in human immunodeficiency virus-infected individuals. Int J Tuberc Lung Dis 1: 1704.
  • 10
    Gennaro M.L., Affouf M., Kanaujia G.V., Brusasca P.N., Mangura B., Reichman L. (2007) Antibody markers of incident tuberculosis among HIV-infected adults in the USA: a historical prospective study. Int J Tuberc Lung Dis 11: 62431.
  • 11
    Laal S., Samanich K.M., Sonnenberg M.G., Belisle J.T., O'leary J., Simberkoff M.S., Zolla-Pazner S. (1997) Surrogate marker of preclinical tuberculosis in human immunodeficiency virus infection: antibodies to an 88-kDa secreted antigen of Mycobacterium tuberculosis. J Infect Dis 176: 13343.
  • 12
    Simonney N., Chavanet P., Perronne C., Leportier M., Revol F., Herrmann J.L., Lagrange P.H. (2007) B-cell immune responses in HIV positive and HIV negative patients with tuberculosis evaluated with an ELISA using a glycolipid antigen. Tuberculosis (Edinb) 87: 10922.
  • 13
    Andersen P., Munk M.E., Pollock J.M., Doherty T.M. (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356: 1099104.
  • 14
    Leyten E.M., Lin M.Y., Franken K.L., Friggen A.H., Prins C., Van Meijgaarden K.E., Voskuil M.I., Weldingh K., Andersen P., Schoolnik G.K., Arend S.M., Ottenhoff T.H., Klein M.R. (2006) Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect 8: 205260.
  • 15
    Matsumoto S., Yukitake H., Furugen M., Matsuo T., Mineta T., Yamada T. (1999) Identification of a novel DNA-binding protein from Mycobacterium bovis bacillus Calmette-Guérin. Microbiol Immunol 43: 102736.
  • 16
    Ohara N., Ohara N., Naito M., Miyazaki C., Matsumoto S., Tabira Y., Yamada T. (1997) HrpA, a new ribosome-associated protein which appears in heat-stressed Mycobacterium bovis bacillus Calmette- Guérin. J Bacteriol 179: 64958.
  • 17
    Roberts D.M., Liao R.P., Wisedchaisri G., Hol W.G., Sherman D.R. (2004) Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. J Biol Chem 279: 23 0827.
  • 18
    Wiker H.G., Harboe M. (1992) The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 56: 64861.
  • 19
    Wilkinson K.A., Stewart G.R., Newton S.M., Vordermeier H.M., Wain J.R., Murphy H.N., Horner K., Young D.B., Wilkinson R.J. (2005) Infection biology of a novel alpha-crystallin of Mycobacterium tuberculosis: Acr2. J Immunol 174: 423743.
  • 20
    Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., Holland S.M., Horsburgh R., Huitt G., Iademarco M.F., Iseman M., Olivier K., Ruoss S., Von Reyn C.F., Wallace, R.J., Jr., Winthrop K. (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367416.
  • 21
    Steingart K.R., Dendukuri N., Henry M., Schiller I., Nahid P., Hopewell P.C., Ramsay A., Pai M., Laal S. (2009) Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin Vaccine Immunol 16: 26076.
  • 22
    Abebe F., Holm-Hansen C., Wiker H.G., Bjune G. (2007) Progress in serodiagnosis of Mycobacterium tuberculosis infection. Scand J Immunol 66: 17691.
  • 23
    Steingart K.R., Henry M., Laal S., Hopewell P.C., Ramsay A., Menzies D., Cunningham J., Weldingh K., Pai M. (2007) Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med 4: e202.
  • 24
    Boon C., Dick T. (2002) Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J Bacteriol 184: 67607.
  • 25
    Locht C., Hougardy J.M., Rouanet C., Place S., Mascart F. (2006) Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. Tuberculosis (Edinb) 86: 3039.
  • 26
    Park H.D., Guinn K.M., Harrell M.I., Liao R., Voskuil M.I., Tompa M., Schoolnik G.K., Sherman D.R. (2003) Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 48: 83343.
  • 27
    Roupie V., Romano M., Zhang L., Korf H., Lin M.Y., Franken K.L., Ottenhoff T.H., Klein M.R., Huygen K. (2007) Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect Immun 75: 9419.
  • 28
    Belisle J.T., Vissa V.D., Sievert T., Takayama K., Brennan P.J., Besra G.S. (1997) Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276: 14202.
  • 29
    Backus K.M., Boshoff H.I., Barry C.S., Boutureira O., Patel M.K., D'Hooge F., Lee S.S., Via L.E., Tahlan K., Barry III, C.E., Davis B.G. (2011) Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis. Nat Chem Biol 7: 22835.
  • 30
    Matsunaga I., Naka T., Talekar R.S., Mcconnell M.J. Katoh K., Nakao H., Otsuka A., Behar S.M., Yano I., Moody D.B., Sugita M. (2008) Mycolyltransferase-mediated glycolipid exchange in Mycobacteria. J Biol Chem 283: 28 83541.
  • 31
    Layre E., Collmann A., Bastian M., Mariotti S., Czaplicki J., Prandi J., Mori L., Stenger S., De Libero G., Puzo G., Gilleron M. (2009) Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted T cells. Chem Biol 16: 8292.
  • 32
    Lewin A., Baus D., Kamal E., Bon F., Kunisch R., Maurischat S., Adonopoulou M., Eich K. (2008) The mycobacterial DNA-binding protein 1 (MDP1) from Mycobacterium bovis BCG influences various growth characteristics. BMC Microbiol 8: 91.
  • 33
    Matsumoto S., Furugen M., Yukitake H., Yamada T. (2000) The gene encoding mycobacterial DNA-binding protein I (MDPI) transformed rapidly growing bacteria to slowly growing bacteria. FEMS Microbiol Lett 182: 297301.
  • 34
    Niki M., Niki M., Tateishi Y., Ozeki Y., Kirikae T., Lewin A., Inoue Y., Matsumoto M., Dahl J.L., Ogura H., Kobayashi K., Matsumoto S. (2012) A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria. J Biol Chem 287: 27 74352.
  • 35
    Takatsuka M., Osada-Oka M., Satoh E.F., Kitadokoro K., Nishiuchi Y., Niki M., Inoue M., Iwai K., Arakawa T., Shimoji Y., Ogura H., Kobayashi K., Rambukkana A., Matsumoto S. (2011) A histone-like protein of mycobacteria possesses ferritin superfamily protein-like activity and protects against DNA damage by Fenton reaction. PLoS ONE 6: e20985.